An in-depth look into important developments in this fast changing legal landscape.
Bird & Bird's award winning International Life Sciences Group would like to invite you and your colleagues to a seminar to be held in Geneva, Switzerland, which is an international hub for the life sciences sector.
Legal input is crucial at the earliest stages in strategic planning and is fundamental to succeeding in this competitive, extremely challenging, and potentially lucrative market. Given the high cost and risk inherent in biotech drug development it is imperative to consider the legal and regulatory aspects in order to ensure success.
The seminar will be beneficial for general and in-house counsel, life cycle management professionals and strategic planners, professionals involved in clinical development and product regulation and medical directors.
This seminar, which will include presenters from France, Belgium and the UK, will be held in the picturesque luxury Hôtel Président Wilson, with drinks and canapés to follow.
The programme
Coffee and registration
16.15 - 16.30
Welcome and introduction
16.30 - 16.35
Presentations
16.35 - 18.00
- Biosimilars an update on developments in the US and in the EU: Prospects for global developments?
- Medical applications and scientific research with human cells and tissues: Introduction to the EU regulatory framework
- Licensing issues in the pharma and biotech industry
Canapés and drinks
18.00 - 20.00
RSVP
To RSVP for this event please click here.
Enquiries
Please contact Ulrike Trader
Tel: +33 1 42 68 60 41
Email karla.fryer@twobirds.com for more information
Fee
This event is free of charge
CPD accreditation
This seminar is SRA accredited with 2.5 CPD hours.